KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Quest Diagnostics (DGX) over the last 12 years, with Q3 2025 value amounting to $137.0 million.

  • Quest Diagnostics' Long-Term Investments rose 960.0% to $137.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.0 million, marking a year-over-year increase of 960.0%. This contributed to the annual value of $123.0 million for FY2024, which is 888.89% down from last year.
  • Latest data reveals that Quest Diagnostics reported Long-Term Investments of $137.0 million as of Q3 2025, which was up 960.0% from $136.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Long-Term Investments registered a high of $527.0 million during Q1 2021, and its lowest value of $111.0 million during Q2 2021.
  • Moreover, its 5-year median value for Long-Term Investments was $134.0 million (2025), whereas its average is $153.5 million.
  • Its Long-Term Investments has fluctuated over the past 5 years, first plummeted by 7757.58% in 2021, then skyrocketed by 3243.24% in 2022.
  • Quarter analysis of 5 years shows Quest Diagnostics' Long-Term Investments stood at $141.0 million in 2021, then dropped by 6.38% to $132.0 million in 2022, then increased by 2.27% to $135.0 million in 2023, then dropped by 8.89% to $123.0 million in 2024, then grew by 11.38% to $137.0 million in 2025.
  • Its last three reported values are $137.0 million in Q3 2025, $136.0 million for Q2 2025, and $134.0 million during Q1 2025.